NYU Arts & Science biologists Rahul Satija and Neville Sanjana have been named to the Clarivate Analytics 2023 list of Highly Cited Researchers. The list recognizes scientists for publishing influential research papers that rank in the top 1% by citations in their fields, what Clarivate calls a “one in 1,000” distinction.
Clarivate noted the societal impact of the winning researchers: “The list identifies and celebrates exceptional individual researchers whose significant and broad influence in their fields translates to impact in their research community and innovations that make the world healthier, more sustainable and more secure. Their contributions resonate far beyond their individual achievements, strengthening the foundation of excellence and innovation in research.”
Rahul Satija was one of only 238 scientists to be recognized as a Highly Cited Researcher in two fields: Molecular Biology and Genetics, and Biology and Biochemistry. An Associate Professor of Biology, Satija earned his PhD from Oxford in Statistics and is leading research into single cell genomics, transcriptional regulation, and computational biology. The Satija Lab's goal is to decipher the role of cellular heterogeneity related to molecular structure, function, and the regulation of complex biological systems. Through a bottom-up approach, the Satija Lab studies how diverse cells work together when it comes to biological processes and behaviors—from single cell analysis to the effect of autoimmune diseases. Satija's recent publications can also be found on PubMed.
Associate Professor of Biology Neville Sanjana earned his PhD from MIT in Brain & Cognitive Sciences and currently studies bioengineering, neuroscience, and cancer biology. His Sanjana Lab is developing technologies to aid in understanding the role of genetic variants in diseases of the nervous system and cancer. To do so, Sanjana and his team explore the human genome to expand knowledge of drug resistance, metastasis, and how tumors evade immunotherapy. His work will continue to advance through two recently awarded grants: a $4.5M NIH National Human Genome Research Institute Grant and a $4.5M BD2 Consortium Grant. Sanjana's recent publications can be found at PubMed, maintained by the NIH's National Library of Medicine.